Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q3 2016 call → NOWe need to determine if management conveys that the business currently being done is visibly outgrowing the company's own size. Look for statements about current activity, demand, commitments that are large relative to the company's small size. Key points from transcript: - Revenue growth ~30% vs prior year and recent quarters. - Adjusted EBITDA positive $340k. - They have $150M revenue under $600M BPA umbrella. - Coast Guard national task order pending, but they say it's weeks away, could add in excess of $10M in 2017, and could become largest client. - They are first to receive ATO for ECA PIV-I credentials, sole authorized provider, with 12-month competitive advantage. They mention 40 million credentials needed, but that's a market estimate. - AT&T relationship for IoT, they are selected as security solution, AT&T funding integration, launch accelerated to April 2017. They say it's a major opportunity but no numbers. - They mention they provide TLM services to 225,000 devices, telecom analytics to 1.1 million endpoints. Do they convey that current business is disproportionately large relative to company size? They talk about growth, but the specific large opportunities like Coast Guard, AT&T, ECA PIV-I are either pending or future. The Coast Guard is still not yet awarded, they say "we are confident that it is only weeks away" and "could add in excess of $10 million" - that's prospective. AT&T is also future launch. The ECA PIV-I is a new credential, they are first to get ATO, but that's a market opportunity, not current revenue. They do mention current revenue growth and that they are achieving profitability, but that's normal growth. They don't explicitly say "this is large relative to our size" in a way that indicates a disproportion. They mention they have $150M under BPA, but that's cumulative, not current. They say they are the sole provider for ECA PIV-I, but that's a market position, not current volume. The question asks: does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size? That is, current activity, demand, commitments arriving at a scale large relative to small company. The examples given: winning business large next to current revenue, a single customer could rival meaningful share, handling volumes that would have been out of reach, etc.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.